Contact sensitivity reactions in the oral mucosa

Acta Odontologica Scandinavica

Volumn 59, Issue 4, 2001, Pages 248-254

  Ahlfors, Eva Elisabeth ^a   Lyberg, Torstein ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b NONE

Author keywords

Contact sensitivity; Haptens; Mouse and rat models; Oral mucosa; T cells

Indexed keywords

DODECYL SULFATE SODIUM; HAPTEN; IMMUNOLOGICAL ADJUVANT; IRRITANT AGENT; OXAZOLONE; SURFACTANT; TRINITROBENZENESULFONIC ACID;

ANIMAL; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTACT DERMATITIS; DELAYED HYPERSENSITIVITY; DRUG EFFECT; HUMAN; IMMUNOLOGY; MOUSE; MOUTH MUCOSA; RAT; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; DERMATITIS, CONTACT; HAPTENS; HUMANS; HYPERSENSITIVITY, DELAYED; IRRITANTS; MICE; MODELS, ANIMAL; MOUTH MUCOSA; OXAZOLONE; RATS; SODIUM DODECYL SULFATE; SURFACE-ACTIVE AGENTS; T-LYMPHOCYTES; TRINITROBENZENESULFONIC ACID;

EID: 0035431724     PISSN: 00016357     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016350152509283     Document Type: Article

References (39)

1. Nyquist G. A study of denture sore mouth: an investigation of traumatic, allergic and toxic lesions of the oral mucosa arising from the use of full dentures [thesis]. Acta Odontol Scand 1952;10 Suppl 9.
2. Lowney ED. Immunologic unresponsiveness to a contact sensitizer in man. J Invest Dermatol 1968;51:411-7.
3. Ranki A, Kanerva L, Førstrøm L, Konttinen Y, Mustakallio KK. T and B lymphocytes, macrophages and Langerhans cells during the course of contact allergic and irritant reactions in man. Acta Derm Venereol 1933;63:376-83.
4. Brand CU, Hunziker T, Yawalkar N, Braathen LR. IL-1 beta protein in human skin lymph does not discriminate allergic from irritant contact dermatitis. Contact Dermatitis 1996;35:152-6.
5. Tsuruta J, Sugisaki K, Dannenberg AM Jr, Yoshimura T, Abe Y, Mounts P. The cytokines NAP-1 (IL-8). MCP-1, IL-1 beta, and GRO in rabbit inflammatory skin lesions produced by the chemical irritant sulfur mustard. Inflammation 1996;20:293-318.
6. Hoefakker S, Caubb M, van't Erve EH Roggeveen MJ. Boersma WJ, van Joost T, et al. In vivo cytokine profiles in allergic and irritant contact dermatitis. Contact Dermatitis 1995;33:258-66.
7. Kondo S, Pastore S, Shiviji GM, McKenzie RC, Sander DN, Characterization of epidermal cytokine profiles in sensitization and elicitation phases of allergic contact dermatitis as well as irritant contact dermatitis in mouse skin. Lymphokine Cytokine Res 1994;13:367-75.
8. Sanchez R, Jonsson R, Ahlfors E, Backman K, Czerkinsky C. Oral lesions of lupus erythematosus patients in relation to other chronic inflammatory oral diseases: an immunologic study. Scand J Dent Res 1988;96:569-78.
9. Takeuchi Y, Iwase N, Suzuki M, Tsuyuki S. Lichen planus with involvement of all twenty nails and the oral mucous membrane. J Dermatol 2000:27:94-8.
10. McGivern B, Petnberton M, Theater E D, Buchanan JA, Thornhill MH. Delayed and immediate hypersensitivity reactions associated with the use of amalgam. Br Dent J 2000;188: 73-6.
11. Koch P, Bahmer FA. Oral lesions and symptoms related to metals used in denial restorations: a clinical, allergological, and histological study. J Am Acad Dermatol 1999;41:422-30.
12. Bergdahl J, Tillberg A, Stenman E Odontologic survey of referred patients with symptoms allegedly caused by electricity or visual display units. Acta Odontol Scand 1998;56:303-7.
13. Tosti A, Piraccin, BM, Peluso AM. Contact and irritant stomatitis. Semin Cutan Med Surg 1998;16:314-9.
14. Hochman N, Zalkind M. Hypersensitivity to methyl methacrylate: mode of treatment. J Prosthet Dent 1997;77:93-6.
15. Healy CM, Cruchley AT, Thornhill MH, Williams DM. The effect of sodium lauryl sulphate, triclosan and zinc on the permeability of normal oral mucosa. Oral Dis 2000;6:118-23.
16. Fartasch M, Schnetz E, Diepgen TL. Characterization of detergent-induced barrier alterations - effect of barrier cream on irritation. J Invest Dermatol Symp Proc 1998;3:121-7.
17. Mustafa M, Bakhiet M, Wondimu B, Modeer T. Effect of triclosan on interferon-gamma production and major histocompatibility complex class II expression in human gingival fibroblasts. J Clin Periodontol 2000;27:733-77.
18. Skaare AB, Kjarrheim V, Barkvoll P, Rolla G. Does the nature of the solvent affect the anti-inflammatory capacity of triclosan? An experimental study. J Clin Periodontol 1997;24:124-8.
19. Ahlfors E, Czerkinsky C. Contact sensitivity in the murine oral mucosa. I. An experimental model of delayed type hypersensitivity at mucosal surfaces. Clin Exp Immunol 1991;86:449-56.
20. Ahlfors E, Larsson P. Light microscopic study of experimental cell-mediated immunity in rat oral mucosa. Scand J Dent Res 1984;92:549-56.
21. Ahlfors E, Jonsson R, Czerkinsky C. Experimental T cell-mediated inflammatory reactions in the murine oral mucosa. II. Immunohistochemical characterization of resident and infiltrating cells. Clin Exp Immunol 1996;104:297-305.
22. Eriksson K, Ahlfors E, George-Chandy A, Kaiserlian D, Czerkinsky C. Antigen presentation in the murine oral epithelium. Immunology 1996;88:147-52
23. Adams D, Williamson JJ, Dolby AE. Delayed hypersensitivity response in guinea pig oral mucosa. J Pathol 1969;97:495-501.
24. Mohammad AR, Mincer HH. Dinitrochlorobenzene contact hypersensitivity in the hamster cheek pouch. J Oral Pathol 1976; 5:169-74.
25. Warfvinge G, Larsson Å. Immunocytochemical analysis of early focal cellular infiltrates in experimental oral contact hypersensitivity. Acta Derm Venereol 1991;71:377-83.
26. Hasséus B, Dahlgren U, Bergenhotz G, Jontell M. Antigen presenting capacity of Langerhans cells from rat oral epithelium. J Oral Pathol Med 1995;24:56-60.
27. van Wilsem EJG, van Hoogstraten I, Bréve J, Zaman Y. Kraal G. In vivo antigen presentation capacity of dendritic cells from oral mucosa and skin draining lymph nodes. Adv Exp Med Biol 1994;355:63-7.
28. van Wilsem EJ. van Hoogstraaten IM, Bréve J, Scheper RJ. Kraal G. Dendritic cells of the oral mucosa and the induction of oral tolerance. A local affair. Immunology 1994;83:128-32.
29. Barett AW, Ross DA, Goodacre JA. Purified human oral mucosal Langerhans cells function as accessory cells in vitro. Clin Exp Immunol 1993;92:158-63.
30. Kim SK, Reed DS, Heath WR, Carbone F, Lefrancois L. Activation and migration of CD8 T cells in the intestinal mucosa. J Immunol 1997;159:4295-306.
31. Effendy I. Maibach HI. Surfactants and experimental irritant contact dermatitis. Contact Dermatitis 1995;33:217-25.
32. Ahlfors EE, Warfvinge G, Larsson PÅ. Toxic lesions in rat oral mucosa: toxic thresholds and sensitizing propensity of DNFB and SLS in a rat model [abstract]. Swed Dent J 1986;6:254.
33. Warfvinge G, Ahlfors EE, Larsson PA. Toxic lesions in rat oral mucosa: the early stages of SLS-induced lesions, a time sequence study [abstract]. Swed Dent J 1986;6:254.
34. Shimizu T, Munn CG, Streilein JW. Transepidermal induction of contact hypersensitivity in mice with a water-soluble hapten. J Invest Dermatol 1993;101:749-53.
35. MacDonald TT, Monteleone G, Pender SL. Recent developments in the immunology of inflammatory bowel disease. Scand J Immunol 2000:51:2-9.
36. Boirivant M, Fuss IJ, Ferroni L, De Pascale M, Strober W. Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid; colitis. J Immunol 2001;166:22-32.
37. Tomasi T. Oral tolerance. Transplantation 1980;29:353-6.
38. Marth T, Ring S, Schulte D, Klensch N, Strober W, Kelsall BL, et al. Antigen-induced mucosal T cell activation is followed by Th1 T cell suppression in continuously fed ovalbumin TCR-transgenic mice. Eur J Immunol 2000;30:3478-86.
39. Ahlfors E, Czerkinsky C. Suppression of delayed-type hypersensitivity in the murine oral mucosa by prior intragastric administration of hapten. Scand J Immunol 1997;46:268-73.